KUALA LUMPUR, Sept 7 (Bernama) -- Lysando AG, market leader for antimicrobial proteins has announced the addition of Jorge Cortell to its esteemed Advisory Board, marking a significant milestone in the company's growth.
As a serial entrepreneur and renowned visionary in healthcare technology, Cortell brings a wealth of expertise to Lysando's strategic direction.
“Joining Lysando represents an exciting opportunity to contribute my expertise in cutting-edge technologies and their potential to revolutionise healthcare.
“I believe in Lysando's mission to address the global challenge of antimicrobial resistance and to improve patient outcomes through transformative therapeutic solutions,” said Cortell in a statement.
Cortell's background positions him as a thought leader in the global industry, having served as a Senior Advisor for Healthcare and Life Sciences at Harvard University Innovation Laboratories, and a technology advisor to NLC, Europe's largest HealthTech Venture Builder.
His profound understanding of both tech and business landscapes makes him an asset in guiding Lysando towards new heights of success.
Cortell's involvement on the Advisory Board promises to drive the company's mission, ultimately ushering in a future of improved quality of life for all.
-- BERNAMA
No comments:
Post a Comment